You have 9 free searches left this month | for more free features.

C-peptide

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction Trial in Paris (Glibenclamide, Pharmacokinetics

Not yet recruiting
  • Transient; Hypoglycemia, Neonatal
  • +2 more
  • Paris, France
    Hopital Necker - Enfants malades
Jan 6, 2023

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

Development ofNovel Method to Measure Insulin Sensitivity in

Completed
  • Insulin Sensitivity
  • 24h Continuous glucose monitoring and urinary C-peptide collection
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Jun 12, 2022

Carotid Atherosclerosis Trial in Saint Louis (Cu[64]-25%-CANF-Comb PET-MR)

Completed
  • Carotid Atherosclerosis
  • Cu[64]-25%-CANF-Comb PET-MR
  • Saint Louis, Missouri
    Washington University in St.Louis
Oct 13, 2022

Development of Predictive Biomarkers

Completed
  • Type1diabetes
  • Mixed Meal Tolerance Test
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Nov 28, 2021

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Healthy Trial (Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide, Peptide complexed HA Age Defying Gel with

Not yet recruiting
  • Healthy
  • Peptide complexed HA Age Defying Gel with Vitamin C & Niacinamide
  • +4 more
  • (no location specified)
Dec 11, 2022

Polycystic Ovary Syndrome, c Type Natriuretic Peptide, Menstrual Irregularity Trial in Nicosia (C type natriuretic peptide)

Completed
  • Polycystic Ovary Syndrome
  • +3 more
  • C type natriuretic peptide
  • Nicosia, Cyprus
    Near East University Faculty of Medicine
Oct 7, 2021

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Recruiting
  • Carotid Atherosclerosis
  • +2 more
  • Los Angeles, California
  • +1 more
Apr 27, 2023

Diabetes Type One in Pregnancy and Continuos Glucose Monitoring

Recruiting
  • Large-for-gestational-age Neonates
  • +4 more
    • Zagreb, Croatia
      University hospital centre Zagreb
    Aug 2, 2021

    Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

    Completed
    • Hiv
    • Autologous CD4 T-Cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 13, 2022

    Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)

    Active, not recruiting
    • Post Concussive Symptoms
    • Early intervention programme
    • Enhanced usual care
    • (no location specified)
    Apr 11, 2023

    Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)

    Completed
    • Alcohol Use Disorder
    • Pittsburgh, Pennsylvania
      University of PIttsburgh PET Facility
    Jul 8, 2022

    Hyperlipidemias Trial in Toronto (Teduglutide, Placebo)

    Completed
    • Hyperlipidemias
    • Toronto, Ontario, Canada
    • +1 more
    May 18, 2022

    Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

    Not yet recruiting
    • Diffuse Hemispheric Glioma, H3 G34-Mutant
    • Dendritic Cell Tumor Peptide Vaccine
    • +6 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jul 13, 2022

    Prostate Cancer Trial in Beijing (11C-Choline)

    Recruiting
    • Prostate Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 11, 2021

    HIV Trial in Rochester, Nashville, Seattle (HIV-1 C4-V3 Polyvalent Peptide Vaccine)

    Completed
    • HIV Infections
    • HIV-1 C4-V3 Polyvalent Peptide Vaccine
    • Rochester, New York
    • +2 more
    Oct 27, 2021

    Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +4 more
    • KRAS-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    Type 1 Diabetes Trial in Uppsala (Liraglutide, Placebo for liraglutide)

    Completed
    • Type 1 Diabetes
    • Uppsala, Sweden
      Uppsala University Hospital
    Nov 4, 2020

    Type 1 Diabetes Trial in Duarte (Tolerogenic Dendritic Cell Vaccine)

    Recruiting
    • Type 1 Diabetes Mellitus
    • Tolerogenic Dendritic Cell Vaccine
    • Duarte, California
      City of Hope Medical Center
    Jul 26, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +20 more
    • Neoantigen Peptide Vaccine
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 7, 2022

    Diabetes, Type 2, Depressive Symptoms Trial in Jakarta Pusat (Cholecalciferol 4000 IU Oral Capsule, Liquid Filled, Placebo)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Depressive Symptoms
    • Cholecalciferol 4000 IU Oral Capsule, Liquid Filled
    • Placebo
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Cipto Mangunkusumo National General Hospital
    Jun 7, 2021

    Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

    Recruiting
    • Breast Adenocarcinoma
    • +7 more
    • Multi-epitope HER2 Peptide Vaccine TPIV100
    • +5 more
    • Scottsdale, Arizona
    • +26 more
    Aug 17, 2022

    HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)

    Completed
    • HIV Infections
    • Chicago, Illinois
    • +2 more
    Oct 28, 2021

    Vitamin D Deficiency Trial in Amman (VD3, Omega-3FA, VD3 and Omega-3FA)

    Completed
    • Vitamin D Deficiency
    • VD3
    • +3 more
    • Amman, Jordan
      Applied Science University
    Jul 12, 2020